Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-07-13 20:43 | 2020-07-09 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $170.00 | 11,000 | $1,870,000 | 18,646 | -37.1% |
| 2020-06-18 16:36 | 2020-06-16 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $162.94 | 17,000 | $2,770,000 | 29,646 | -36.4% |
| 2020-06-09 23:52 | 2020-06-05 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $150.00 | 10,000 | $1,500,000 | 46,646 | -17.7% |
| 2020-03-13 18:02 | 2020-03-11 | CTS | CTS CORP | Zulueta Alfonso G | Director | Printed Circuit Boards | BUY | $22.40 | 2,663 | $59,639 | 13,013 | +25.7% |
| 2020-03-10 23:09 | 2020-03-09 | CTS | CTS CORP | Zulueta Alfonso G | Director | Printed Circuit Boards | BUY | $22.83 | 1,750 | $39,954 | 10,350 | +20.3% |
| 2019-12-10 00:37 | 2019-12-06 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $120.00 | 4,500 | $540,000 | 29,306 | -13.3% |
| 2019-09-23 22:54 | 2019-09-20 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $117.00 | 4,500 | $526,500 | 33,806 | -11.7% |
| 2019-09-09 18:59 | 2019-09-03 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $112.96 | 19,500 | $2,202,714 | 38,306 | -33.7% |
| 2019-09-04 22:09 | 2019-09-03 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $112.91 | 19,500 | $2,201,745 | 38,306 | -33.7% |
| 2019-04-16 21:48 | 2019-04-12 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $124.65 | 10,000 | $1,246,500 | 57,806 | -14.7% |
| 2019-02-05 00:32 | 2019-01-31 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $120.00 | 4,000 | $480,000 | 41,224 | -8.8% |
| 2018-10-05 21:08 | 2018-10-04 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $114.64 | 7,000 | $802,480 | 45,224 | -13.4% |
| 2018-09-20 00:47 | 2018-09-17 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $106.31 | 6,000 | $637,830 | 52,224 | -10.3% |
| 2017-12-06 01:35 | 2017-12-04 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $86.00 | 3,532 | $303,752 | 40,048 | -8.1% |
| 2017-11-13 20:55 | 2017-11-10 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $83.67 | 2,003 | $167,591 | 43,580 | -4.4% |
| 2017-02-08 18:02 | 2017-02-06 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP& Pres., Emerging Markets | Pharmaceutical Preparations | SALE | $77.66 | 15,000 | $1,164,900 | 45,583 | -24.8% |
| 2016-04-28 22:43 | 2016-04-27 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP& Pres., Emerging Markets | Pharmaceutical Preparations | SALE | $76.27 | 12,000 | $915,240 | 45,101 | -21.0% |
| 2016-02-02 23:32 | 2016-01-29 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP& Pres., Emerging Markets | Pharmaceutical Preparations | SALE | $78.75 | 5,000 | $393,750 | 57,101 | -8.1% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.